119 related articles for article (PubMed ID: 9676341)
1. [Pellet technology. Sustained-release pellets in hard gelatin capsules--a suitable dosage form for theophylline].
Laicher A; Fuchs WS
Arzneimittelforschung; 1998 May; 48(5A):540-7. PubMed ID: 9676341
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
[TBL] [Abstract][Full Text] [Related]
3. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].
Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M
Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353
[TBL] [Abstract][Full Text] [Related]
4. [Experience in scaling up the film coating process for theophylline sustained-release pellets in mass production].
Grunenberg P; Lorck C; Jünger H; Laicher A
Arzneimittelforschung; 1998 May; 48(5A):547-51. PubMed ID: 9676342
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
[TBL] [Abstract][Full Text] [Related]
7. [The effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained-release theophylline preparation].
Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
Arzneimittelforschung; 1998 May; 48(5A):561-8. PubMed ID: 9676345
[TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
[TBL] [Abstract][Full Text] [Related]
10. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
Wangemann M; Retzow A; Vens-Cappell B
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
[TBL] [Abstract][Full Text] [Related]
12. [Requirements for product quality of theophylline sustained-release preparations].
Fuchs WS; Hens C; von Nieciecki A
Arzneimittelforschung; 1998 May; 48(5A):556-61. PubMed ID: 9676344
[TBL] [Abstract][Full Text] [Related]
13. [In vivo verification of in vitro release specifications of a theophylline sustained-release preparation].
von Nieciecki A; Fuchs WS; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1998 May; 48(5A):580-3. PubMed ID: 9676348
[TBL] [Abstract][Full Text] [Related]
14. A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS).
Abdul S; Chandewar AV; Jaiswal SB
J Control Release; 2010 Oct; 147(1):2-16. PubMed ID: 20493217
[TBL] [Abstract][Full Text] [Related]
15. [Controlled release of pseudoephedrine HCl from pellets].
Vertommen J
Verh K Acad Geneeskd Belg; 1997; 59(6):451-88. PubMed ID: 9543819
[TBL] [Abstract][Full Text] [Related]
16. [The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation].
Fuchs WS; Jakobs R; Grunenberg P; Weiss G; Profitlich T; von Nieciecki A; Klemm FH; Laicher A; Stanislaus F
Arzneimittelforschung; 1998 May; 48(5A):552-6. PubMed ID: 9676343
[TBL] [Abstract][Full Text] [Related]
17. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
[TBL] [Abstract][Full Text] [Related]
18. [A review on liquid-filled hard gelatin capsules].
Ma JH; Yang M; Zeng M; Chen XM; Lan J
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):602-5. PubMed ID: 18536390
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of ofloxacin sustained release pellets.
Cui Y; Zhang Y; Tang X
Int J Pharm; 2008 Aug; 360(1-2):47-52. PubMed ID: 18538518
[TBL] [Abstract][Full Text] [Related]
20. [Extrusion/spheronization: an important method for the production of the pellet dosage form].
Häring A; Rabisková M
Ceska Slov Farm; 2007 Jan; 56(1):11-6. PubMed ID: 17432276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
